论文部分内容阅读
抗炎药一直是世界范围内研究和开发均居领先地位的治疗药物,在Scripe每年列出的新产品中,抗炎药一直排在第二位。截至1987年12月止,一年中,新开发的抗炎药物临床前共计139种,临床试验情况不详的有2种,进入Ⅰ期临床的有12种,Ⅱ期20种,已上市3种,目前包括1987年前上市的抗炎药的注册总数达230种。在所有的治疗药物类别中,抗炎药的销售额也一直名列前矛,预计到1991年的世界总销售将达60亿美元。可见抗炎药的市场潜力巨大,各国制药公司对此竞相开发。
Anti-inflammatory drugs have been the world’s leading research and development of therapeutic drugs, anti-inflammatory drugs has been ranked second in the list of new products Scripe each year. As of December 1987, a year, the newly developed anti-inflammatory drugs pre-clinical total of 139 species, the clinical trial is unknown in two species into the clinical stage of 12, 20, has been listed 3 At present, the total number of anti-inflammatory drugs marketed before 1987 is 230. Anti-inflammatory drug sales have also been among the top therapeutic drugs in all categories, with total world sales expected to reach $ 6 billion by 1991. Shows the huge market potential of anti-inflammatory drugs, pharmaceutical companies in this country competing development.